Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Barbara Wisner"'
Autor:
Angela Gentile, Maria Paula Della Latta, Mercedes Bloch, Luisina Martorelli, Barbara Wisner, Cecilia Sorhouet Pereira, Mabel Regueira, Maria Del Valle Juarez, Veronica Umido, Adriana Efron
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247991 (2021)
BackgroundNeisseria meningitidis (Nm) pharyngeal carriage is a necessary condition for invasive disease. We present the first carriage study in children in Buenos Aires, Argentina, considering 2017 as a transition year. Aims: to assess the rate of Nm
Externí odkaz:
https://doaj.org/article/c8a0441b00724b1b8d4178d8174ce863
Autor:
Cecilia Sorhouet Pereira, Maria Del Valle Juarez, Angela Gentile, Luisina Martorelli, Mabel Regueira, Adriana M. Efron, Veronica Umido, Barbara Wisner, Mercedes Bloch, Maria Paula Della Latta
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0247991 (2021)
PLoS ONE, Vol 16, Iss 3, p e0247991 (2021)
Background Neisseria meningitidis (Nm) pharyngeal carriage is a necessary condition for invasive disease. We present the first carriage study in children in Buenos Aires, Argentina, considering 2017 as a transition year. Aims: to assess the rate of N
Autor:
Mabel Regueira, Veronica Umido, Adriana M. Efron, Luisina Martorelli, Cecilia Sorhouet Pereira, Barbara Wisner, Maria Del Valle Juarez, Mercedes Bloch, Maria Paula Della Latta, Angela Gentile
Publikováno v:
Open Forum Infectious Diseases
Background Neisseria meningitidis (Nm) pharyngeal carriage is a necessary condition for invasive meningococcal disease. In 2017, Argentina introduced a tetravalent meningococcal conjugated vaccine (MenACYW) to the National Immunization Program for ch
Autor:
Barbara Wisner, Cecilia Sorohuet, Mabel Regueira, Luisina Martonelli, Mercedes Bloch, Veronica Umido, Maria Del Valle Juarez, Angela Gentile, Adriana M. Efron, Maria Paula Della Latta
Publikováno v:
Open Forum Infectious Diseases
Background Neisseria meningitides (Nm) cause different types of invasive infections.Nm pharyngeal carriage is a necessary condition for invasive meningococcal disease. In 2017 Argentina introduced a tetravalent meningococcal conjugated vaccine (MenAC